Rethinking how we classify pituitary tumours: insights from a serious case of prolactinoma

W Bashari, A Mohammed - Endocrine Abstracts, 2024 - endocrine-abstracts.org
Prolactinomas are a common type of pituitary tumours, making up about 40% of these
tumours in total, with an estimated occurrence of 40-50 people per 100, 000. They are more …

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology

E Sbardella, G Farah, A Fathelrahman… - … & Metabolism Case …, 2016 - edm.bioscientifica.com
Pituitary adenomas are a common intracranial neoplasm, usually demonstrating a benign
phenotype. They can be classified according to pathological, radiological or clinical …

Diagnosis and management of prolactinomas: current challenges

S Petersenn, A Giustina - Pituitary, 2020 - Springer
Prolactinoma is the most frequent pituitary adenoma type, accounting for 40–66% in
epidemiological studies [1]. The estimated prevalence in various populations ranges from …

Abstract# 1003567: The Prolactinoma Predicament; To Treat Medically Or Surgically

A Cadesky, R Punati - Endocrine Practice, 2021 - endocrinepractice.org
Discussion This case illustrates the classic presentation of a patient with a large
prolactinoma with hormonal and mass effects. It highlights the role of primary dopamine …

The clinical characteristics, presentation, and treatment outcomes of prolactinomas at Groote Schuur Hospital

MAM Abdalla - 2021 - open.uct.ac.za
Background: Prolactin-secreting tumours (prolactinomas) are the commonest type of
pituitary tumour, accounting for approximately 30 to 40%% of all pituitary adenomas …

What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?

J Phillips, HE East, SE French, E Melcescu… - Hormones, 2012 - Springer
INTRODUCTION Malignant prolactinoma is an exceedingly rare endocrine tumor and
cannot be diagnosed on histological grounds alone. Similarly to other neuroendocrine …

Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma

A Fusco, F Lugli, E Sacco, L Tilaro, A Bianchi… - Pituitary, 2011 - Springer
Prolactinomas in males can be voluminous macroadenomas invading the surrounding
structures. Medical therapy with dopamine agonists (the treatment of choice for these …

Challenges in the management of prolactinomas: A case of partial resistance to high-dose cabergoline in a young male with an invasive giant prolactinoma

LN Cheţan, A Vladan, D Hortopan… - Endocrine …, 2023 - endocrine-abstracts.org
Background: Giant prolactinomas are rare pituitary tumours larger than> 40 mm in diameter,
representing 2–3% of prolactin secreting tumours. Management is challenging especially in …

Malignant prolactinoma: case report and review of the literature

M Kars, F Roelfsema, JA Romijn… - European Journal of …, 2006 - academic.oup.com
Pituitary carcinomas are extremely rare. In general, the initial clinical, biochemical, and
histological characteristics are of minimal utility in distinguishing benign adenomas from …

Dramatic shrinkage of a giant prolactinoma in a male patient under medical management

VV Ippersiel, N Misson, JE Donckier - acta clinica Belgica, 2012 - Taylor & Francis
A 35-year-old man presented with a 6-month history of headache and blurred vision. There
was no diplopia nor restriction of the visual field. He reported decreased sexual drive but no …